nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—epilepsy syndrome	0.355	0.665	CbGaD
Amisulpride—HTR2A—epilepsy syndrome	0.178	0.335	CbGaD
Amisulpride—HTR2A—phrenic nerve—epilepsy syndrome	0.00956	0.103	CbGeAlD
Amisulpride—DRD3—telencephalic ventricle—epilepsy syndrome	0.00726	0.0781	CbGeAlD
Amisulpride—HTR7—locus ceruleus—epilepsy syndrome	0.00685	0.0737	CbGeAlD
Amisulpride—HTR7—vagus nerve—epilepsy syndrome	0.00524	0.0564	CbGeAlD
Amisulpride—HTR2A—locus ceruleus—epilepsy syndrome	0.00427	0.046	CbGeAlD
Amisulpride—HTR7—pons—epilepsy syndrome	0.00395	0.0425	CbGeAlD
Amisulpride—HTR7—autonomic nervous system—epilepsy syndrome	0.00364	0.0392	CbGeAlD
Amisulpride—HTR2A—cerebellar cortex—epilepsy syndrome	0.00348	0.0375	CbGeAlD
Amisulpride—HTR2A—vagus nerve—epilepsy syndrome	0.00327	0.0352	CbGeAlD
Amisulpride—HTR7—telencephalic ventricle—epilepsy syndrome	0.00325	0.035	CbGeAlD
Amisulpride—DRD2—telencephalic ventricle—epilepsy syndrome	0.00307	0.0331	CbGeAlD
Amisulpride—HTR2A—pons—epilepsy syndrome	0.00246	0.0265	CbGeAlD
Amisulpride—HTR2A—autonomic nervous system—epilepsy syndrome	0.00227	0.0244	CbGeAlD
Amisulpride—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00203	0.0218	CbGeAlD
Amisulpride—HTR7—ganglion—epilepsy syndrome	0.00202	0.0218	CbGeAlD
Amisulpride—DRD2—ganglion—epilepsy syndrome	0.00191	0.0206	CbGeAlD
Amisulpride—HTR7—hindbrain—epilepsy syndrome	0.00153	0.0165	CbGeAlD
Amisulpride—DRD2—hindbrain—epilepsy syndrome	0.00145	0.0156	CbGeAlD
Amisulpride—HTR2A—ganglion—epilepsy syndrome	0.00126	0.0136	CbGeAlD
Amisulpride—DRD3—head—epilepsy syndrome	0.00109	0.0117	CbGeAlD
Amisulpride—DRD3—nervous system—epilepsy syndrome	0.00103	0.0111	CbGeAlD
Amisulpride—DRD3—central nervous system—epilepsy syndrome	0.000991	0.0107	CbGeAlD
Amisulpride—HTR2B—forebrain—epilepsy syndrome	0.00099	0.0107	CbGeAlD
Amisulpride—HTR2A—hindbrain—epilepsy syndrome	0.000956	0.0103	CbGeAlD
Amisulpride—Sulpiride—BCHE—epilepsy syndrome	0.000913	0.275	CrCbGaD
Amisulpride—HTR2B—telencephalon—epilepsy syndrome	0.000911	0.0098	CbGeAlD
Amisulpride—HTR7—brainstem—epilepsy syndrome	0.000879	0.00946	CbGeAlD
Amisulpride—HTR7—forebrain—epilepsy syndrome	0.000848	0.00913	CbGeAlD
Amisulpride—Metoclopramide—CHRM1—epilepsy syndrome	0.000841	0.253	CrCbGaD
Amisulpride—DRD2—brainstem—epilepsy syndrome	0.000831	0.00894	CbGeAlD
Amisulpride—DRD2—forebrain—epilepsy syndrome	0.000802	0.00863	CbGeAlD
Amisulpride—DRD3—brain—epilepsy syndrome	0.000786	0.00847	CbGeAlD
Amisulpride—HTR7—telencephalon—epilepsy syndrome	0.00078	0.00839	CbGeAlD
Amisulpride—DRD2—telencephalon—epilepsy syndrome	0.000737	0.00794	CbGeAlD
Amisulpride—Remoxipride—HTR2A—epilepsy syndrome	0.000654	0.197	CrCbGaD
Amisulpride—HTR7—medulla oblongata—epilepsy syndrome	0.000613	0.0066	CbGeAlD
Amisulpride—Remoxipride—CYP2D6—epilepsy syndrome	0.000598	0.18	CrCbGaD
Amisulpride—HTR2B—head—epilepsy syndrome	0.000567	0.0061	CbGeAlD
Amisulpride—HTR7—midbrain—epilepsy syndrome	0.00056	0.00603	CbGeAlD
Amisulpride—HTR2A—brainstem—epilepsy syndrome	0.000548	0.0059	CbGeAlD
Amisulpride—HTR7—spinal cord—epilepsy syndrome	0.000546	0.00588	CbGeAlD
Amisulpride—HTR2B—nervous system—epilepsy syndrome	0.000538	0.00579	CbGeAlD
Amisulpride—DRD2—midbrain—epilepsy syndrome	0.000529	0.0057	CbGeAlD
Amisulpride—HTR2A—forebrain—epilepsy syndrome	0.000529	0.00569	CbGeAlD
Amisulpride—HTR2B—central nervous system—epilepsy syndrome	0.000518	0.00557	CbGeAlD
Amisulpride—HTR2A—telencephalon—epilepsy syndrome	0.000486	0.00524	CbGeAlD
Amisulpride—HTR7—head—epilepsy syndrome	0.000486	0.00523	CbGeAlD
Amisulpride—HTR7—nervous system—epilepsy syndrome	0.00046	0.00496	CbGeAlD
Amisulpride—DRD2—head—epilepsy syndrome	0.000459	0.00494	CbGeAlD
Amisulpride—HTR7—central nervous system—epilepsy syndrome	0.000443	0.00477	CbGeAlD
Amisulpride—DRD2—nervous system—epilepsy syndrome	0.000435	0.00469	CbGeAlD
Amisulpride—HTR7—cerebellum—epilepsy syndrome	0.000433	0.00466	CbGeAlD
Amisulpride—DRD2—central nervous system—epilepsy syndrome	0.000419	0.00451	CbGeAlD
Amisulpride—HTR2B—brain—epilepsy syndrome	0.000411	0.00442	CbGeAlD
Amisulpride—DRD2—cerebellum—epilepsy syndrome	0.00041	0.00441	CbGeAlD
Amisulpride—HTR2A—medulla oblongata—epilepsy syndrome	0.000382	0.00411	CbGeAlD
Amisulpride—HTR7—brain—epilepsy syndrome	0.000352	0.00379	CbGeAlD
Amisulpride—HTR2A—midbrain—epilepsy syndrome	0.000349	0.00376	CbGeAlD
Amisulpride—HTR2A—spinal cord—epilepsy syndrome	0.000341	0.00367	CbGeAlD
Amisulpride—DRD2—brain—epilepsy syndrome	0.000333	0.00358	CbGeAlD
Amisulpride—Metoclopramide—CYP2D6—epilepsy syndrome	0.000314	0.0946	CrCbGaD
Amisulpride—HTR2A—head—epilepsy syndrome	0.000303	0.00326	CbGeAlD
Amisulpride—HTR2A—nervous system—epilepsy syndrome	0.000287	0.00309	CbGeAlD
Amisulpride—HTR2A—central nervous system—epilepsy syndrome	0.000276	0.00298	CbGeAlD
Amisulpride—HTR2A—cerebellum—epilepsy syndrome	0.00027	0.00291	CbGeAlD
Amisulpride—HTR2A—brain—epilepsy syndrome	0.000219	0.00236	CbGeAlD
Amisulpride—Angioedema—Valproic Acid—epilepsy syndrome	0.00013	0.000525	CcSEcCtD
Amisulpride—Somnolence—Lamotrigine—epilepsy syndrome	0.00013	0.000525	CcSEcCtD
Amisulpride—Weight increased—Topiramate—epilepsy syndrome	0.00013	0.000523	CcSEcCtD
Amisulpride—Mental disorder—Pregabalin—epilepsy syndrome	0.00013	0.000523	CcSEcCtD
Amisulpride—Constipation—Carbamazepine—epilepsy syndrome	0.000129	0.000522	CcSEcCtD
Amisulpride—Dizziness—Propofol—epilepsy syndrome	0.000129	0.000521	CcSEcCtD
Amisulpride—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000129	0.000521	CcSEcCtD
Amisulpride—Weight decreased—Topiramate—epilepsy syndrome	0.000129	0.00052	CcSEcCtD
Amisulpride—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000129	0.00052	CcSEcCtD
Amisulpride—Pruritus—Fosphenytoin—epilepsy syndrome	0.000129	0.00052	CcSEcCtD
Amisulpride—Hypersensitivity—Diazepam—epilepsy syndrome	0.000129	0.00052	CcSEcCtD
Amisulpride—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000129	0.000519	CcSEcCtD
Amisulpride—Malnutrition—Pregabalin—epilepsy syndrome	0.000129	0.000519	CcSEcCtD
Amisulpride—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000129	0.000519	CcSEcCtD
Amisulpride—Leukopenia—Valproic Acid—epilepsy syndrome	0.000127	0.000514	CcSEcCtD
Amisulpride—Asthenia—Vigabatrin—epilepsy syndrome	0.000127	0.000514	CcSEcCtD
Amisulpride—Urticaria—Clonazepam—epilepsy syndrome	0.000127	0.000512	CcSEcCtD
Amisulpride—Depression—Topiramate—epilepsy syndrome	0.000127	0.000511	CcSEcCtD
Amisulpride—Dizziness—Midazolam—epilepsy syndrome	0.000126	0.00051	CcSEcCtD
Amisulpride—Tension—Pregabalin—epilepsy syndrome	0.000126	0.00051	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000126	0.000509	CcSEcCtD
Amisulpride—Abdominal pain—Clonazepam—epilepsy syndrome	0.000126	0.000509	CcSEcCtD
Amisulpride—Fatigue—Lamotrigine—epilepsy syndrome	0.000126	0.000509	CcSEcCtD
Amisulpride—Urticaria—Phenytoin—epilepsy syndrome	0.000126	0.000508	CcSEcCtD
Amisulpride—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000126	0.000508	CcSEcCtD
Amisulpride—Pruritus—Vigabatrin—epilepsy syndrome	0.000126	0.000507	CcSEcCtD
Amisulpride—Asthenia—Diazepam—epilepsy syndrome	0.000125	0.000506	CcSEcCtD
Amisulpride—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000125	0.000505	CcSEcCtD
Amisulpride—Constipation—Lamotrigine—epilepsy syndrome	0.000125	0.000505	CcSEcCtD
Amisulpride—Nervousness—Pregabalin—epilepsy syndrome	0.000125	0.000505	CcSEcCtD
Amisulpride—Nausea—Acetazolamide—epilepsy syndrome	0.000125	0.000504	CcSEcCtD
Amisulpride—Dizziness—Levetiracetam—epilepsy syndrome	0.000125	0.000504	CcSEcCtD
Amisulpride—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000125	0.000503	CcSEcCtD
Amisulpride—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000125	0.000503	CcSEcCtD
Amisulpride—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000125	0.000503	CcSEcCtD
Amisulpride—Vomiting—Propofol—epilepsy syndrome	0.000124	0.000501	CcSEcCtD
Amisulpride—Muscle spasms—Pregabalin—epilepsy syndrome	0.000124	0.000499	CcSEcCtD
Amisulpride—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000124	0.000499	CcSEcCtD
Amisulpride—Pruritus—Diazepam—epilepsy syndrome	0.000124	0.000499	CcSEcCtD
Amisulpride—Hypertension—Valproic Acid—epilepsy syndrome	0.000123	0.000496	CcSEcCtD
Amisulpride—Immune system disorder—Gabapentin—epilepsy syndrome	0.000123	0.000494	CcSEcCtD
Amisulpride—Headache—Propofol—epilepsy syndrome	0.000122	0.000494	CcSEcCtD
Amisulpride—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000122	0.000492	CcSEcCtD
Amisulpride—Vomiting—Midazolam—epilepsy syndrome	0.000122	0.00049	CcSEcCtD
Amisulpride—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000122	0.00049	CcSEcCtD
Amisulpride—Asthenia—Felbamate—epilepsy syndrome	0.000121	0.00049	CcSEcCtD
Amisulpride—Anxiety—Valproic Acid—epilepsy syndrome	0.000121	0.000487	CcSEcCtD
Amisulpride—Tremor—Pregabalin—epilepsy syndrome	0.000121	0.000487	CcSEcCtD
Amisulpride—Dizziness—Fosphenytoin—epilepsy syndrome	0.00012	0.000486	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00012	0.000486	CcSEcCtD
Amisulpride—Urticaria—Carbamazepine—epilepsy syndrome	0.00012	0.000485	CcSEcCtD
Amisulpride—Vomiting—Levetiracetam—epilepsy syndrome	0.00012	0.000484	CcSEcCtD
Amisulpride—Headache—Midazolam—epilepsy syndrome	0.00012	0.000483	CcSEcCtD
Amisulpride—Pruritus—Felbamate—epilepsy syndrome	0.00012	0.000483	CcSEcCtD
Amisulpride—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00012	0.000483	CcSEcCtD
Amisulpride—Diarrhoea—Diazepam—epilepsy syndrome	0.00012	0.000483	CcSEcCtD
Amisulpride—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.00012	0.000483	CcSEcCtD
Amisulpride—Asthenia—Zonisamide—epilepsy syndrome	0.000119	0.000479	CcSEcCtD
Amisulpride—Mental disorder—Gabapentin—epilepsy syndrome	0.000119	0.000479	CcSEcCtD
Amisulpride—Agranulocytosis—Topiramate—epilepsy syndrome	0.000119	0.000479	CcSEcCtD
Amisulpride—Dry mouth—Valproic Acid—epilepsy syndrome	0.000119	0.000478	CcSEcCtD
Amisulpride—Agitation—Pregabalin—epilepsy syndrome	0.000118	0.000477	CcSEcCtD
Amisulpride—Headache—Levetiracetam—epilepsy syndrome	0.000118	0.000477	CcSEcCtD
Amisulpride—Malnutrition—Gabapentin—epilepsy syndrome	0.000118	0.000476	CcSEcCtD
Amisulpride—Angioedema—Pregabalin—epilepsy syndrome	0.000118	0.000475	CcSEcCtD
Amisulpride—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000118	0.000474	CcSEcCtD
Amisulpride—Dizziness—Vigabatrin—epilepsy syndrome	0.000117	0.000474	CcSEcCtD
Amisulpride—Pruritus—Zonisamide—epilepsy syndrome	0.000117	0.000473	CcSEcCtD
Amisulpride—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000117	0.000471	CcSEcCtD
Amisulpride—Urticaria—Lamotrigine—epilepsy syndrome	0.000116	0.000469	CcSEcCtD
Amisulpride—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000116	0.000469	CcSEcCtD
Amisulpride—Bradycardia—Topiramate—epilepsy syndrome	0.000116	0.000469	CcSEcCtD
Amisulpride—Nausea—Propofol—epilepsy syndrome	0.000116	0.000468	CcSEcCtD
Amisulpride—Tension—Gabapentin—epilepsy syndrome	0.000116	0.000467	CcSEcCtD
Amisulpride—Vomiting—Fosphenytoin—epilepsy syndrome	0.000116	0.000467	CcSEcCtD
Amisulpride—Diarrhoea—Felbamate—epilepsy syndrome	0.000116	0.000467	CcSEcCtD
Amisulpride—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000116	0.000466	CcSEcCtD
Amisulpride—Dizziness—Diazepam—epilepsy syndrome	0.000116	0.000466	CcSEcCtD
Amisulpride—Leukopenia—Pregabalin—epilepsy syndrome	0.000115	0.000465	CcSEcCtD
Amisulpride—Nervousness—Gabapentin—epilepsy syndrome	0.000115	0.000463	CcSEcCtD
Amisulpride—Asthenia—Clonazepam—epilepsy syndrome	0.000115	0.000462	CcSEcCtD
Amisulpride—Headache—Fosphenytoin—epilepsy syndrome	0.000114	0.00046	CcSEcCtD
Amisulpride—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000114	0.00046	CcSEcCtD
Amisulpride—Asthenia—Phenytoin—epilepsy syndrome	0.000114	0.000459	CcSEcCtD
Amisulpride—Nausea—Midazolam—epilepsy syndrome	0.000114	0.000458	CcSEcCtD
Amisulpride—Muscle spasms—Gabapentin—epilepsy syndrome	0.000114	0.000458	CcSEcCtD
Amisulpride—Diarrhoea—Zonisamide—epilepsy syndrome	0.000113	0.000457	CcSEcCtD
Amisulpride—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000113	0.000457	CcSEcCtD
Amisulpride—Pruritus—Clonazepam—epilepsy syndrome	0.000113	0.000456	CcSEcCtD
Amisulpride—Vomiting—Vigabatrin—epilepsy syndrome	0.000113	0.000455	CcSEcCtD
Amisulpride—Skin disorder—Valproic Acid—epilepsy syndrome	0.000113	0.000455	CcSEcCtD
Amisulpride—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000112	0.000453	CcSEcCtD
Amisulpride—Pruritus—Phenytoin—epilepsy syndrome	0.000112	0.000453	CcSEcCtD
Amisulpride—Nausea—Levetiracetam—epilepsy syndrome	0.000112	0.000452	CcSEcCtD
Amisulpride—Dizziness—Felbamate—epilepsy syndrome	0.000112	0.000451	CcSEcCtD
Amisulpride—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000112	0.00045	CcSEcCtD
Amisulpride—Convulsion—Pregabalin—epilepsy syndrome	0.000112	0.00045	CcSEcCtD
Amisulpride—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000112	0.00045	CcSEcCtD
Amisulpride—Headache—Vigabatrin—epilepsy syndrome	0.000111	0.000449	CcSEcCtD
Amisulpride—Hypertension—Pregabalin—epilepsy syndrome	0.000111	0.000448	CcSEcCtD
Amisulpride—Vomiting—Diazepam—epilepsy syndrome	0.000111	0.000448	CcSEcCtD
Amisulpride—Tremor—Gabapentin—epilepsy syndrome	0.000111	0.000446	CcSEcCtD
Amisulpride—Dizziness—Zonisamide—epilepsy syndrome	0.00011	0.000442	CcSEcCtD
Amisulpride—Headache—Diazepam—epilepsy syndrome	0.00011	0.000442	CcSEcCtD
Amisulpride—Anxiety—Pregabalin—epilepsy syndrome	0.000109	0.000441	CcSEcCtD
Amisulpride—Diarrhoea—Clonazepam—epilepsy syndrome	0.000109	0.000441	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000109	0.000439	CcSEcCtD
Amisulpride—Hypotension—Valproic Acid—epilepsy syndrome	0.000109	0.000438	CcSEcCtD
Amisulpride—Asthenia—Carbamazepine—epilepsy syndrome	0.000109	0.000438	CcSEcCtD
Amisulpride—Agitation—Gabapentin—epilepsy syndrome	0.000109	0.000438	CcSEcCtD
Amisulpride—Diarrhoea—Phenytoin—epilepsy syndrome	0.000108	0.000438	CcSEcCtD
Amisulpride—Nausea—Fosphenytoin—epilepsy syndrome	0.000108	0.000437	CcSEcCtD
Amisulpride—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000108	0.000435	CcSEcCtD
Amisulpride—Angioedema—Gabapentin—epilepsy syndrome	0.000108	0.000435	CcSEcCtD
Amisulpride—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000108	0.000435	CcSEcCtD
Amisulpride—Vomiting—Felbamate—epilepsy syndrome	0.000108	0.000434	CcSEcCtD
Amisulpride—Dry mouth—Pregabalin—epilepsy syndrome	0.000107	0.000432	CcSEcCtD
Amisulpride—Pruritus—Carbamazepine—epilepsy syndrome	0.000107	0.000432	CcSEcCtD
Amisulpride—Headache—Felbamate—epilepsy syndrome	0.000106	0.000428	CcSEcCtD
Amisulpride—Cardiac disorder—Topiramate—epilepsy syndrome	0.000106	0.000427	CcSEcCtD
Amisulpride—Leukopenia—Gabapentin—epilepsy syndrome	0.000106	0.000426	CcSEcCtD
Amisulpride—Dizziness—Clonazepam—epilepsy syndrome	0.000106	0.000426	CcSEcCtD
Amisulpride—Nausea—Vigabatrin—epilepsy syndrome	0.000105	0.000426	CcSEcCtD
Amisulpride—Vomiting—Zonisamide—epilepsy syndrome	0.000105	0.000425	CcSEcCtD
Amisulpride—Insomnia—Valproic Acid—epilepsy syndrome	0.000105	0.000424	CcSEcCtD
Amisulpride—Asthenia—Lamotrigine—epilepsy syndrome	0.000105	0.000423	CcSEcCtD
Amisulpride—Dizziness—Phenytoin—epilepsy syndrome	0.000105	0.000423	CcSEcCtD
Amisulpride—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000104	0.000421	CcSEcCtD
Amisulpride—Nausea—Diazepam—epilepsy syndrome	0.000104	0.000419	CcSEcCtD
Amisulpride—Headache—Zonisamide—epilepsy syndrome	0.000104	0.000419	CcSEcCtD
Amisulpride—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000104	0.000418	CcSEcCtD
Amisulpride—Angiopathy—Topiramate—epilepsy syndrome	0.000104	0.000418	CcSEcCtD
Amisulpride—Pruritus—Lamotrigine—epilepsy syndrome	0.000103	0.000418	CcSEcCtD
Amisulpride—Somnolence—Valproic Acid—epilepsy syndrome	0.000103	0.000417	CcSEcCtD
Amisulpride—Immune system disorder—Topiramate—epilepsy syndrome	0.000103	0.000416	CcSEcCtD
Amisulpride—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000103	0.000416	CcSEcCtD
Amisulpride—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000102	0.000413	CcSEcCtD
Amisulpride—Convulsion—Gabapentin—epilepsy syndrome	0.000102	0.000413	CcSEcCtD
Amisulpride—Skin disorder—Pregabalin—epilepsy syndrome	0.000102	0.000412	CcSEcCtD
Amisulpride—Hypertension—Gabapentin—epilepsy syndrome	0.000102	0.000411	CcSEcCtD
Amisulpride—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000102	0.00041	CcSEcCtD
Amisulpride—Vomiting—Clonazepam—epilepsy syndrome	0.000101	0.000409	CcSEcCtD
Amisulpride—Vomiting—Phenytoin—epilepsy syndrome	0.000101	0.000407	CcSEcCtD
Amisulpride—Nausea—Felbamate—epilepsy syndrome	0.000101	0.000405	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.0001	0.000405	CcSEcCtD
Amisulpride—Vomiting—Oxcarbazepine—epilepsy syndrome	0.0001	0.000405	CcSEcCtD
Amisulpride—Fatigue—Valproic Acid—epilepsy syndrome	0.0001	0.000404	CcSEcCtD
Amisulpride—Anxiety—Gabapentin—epilepsy syndrome	0.0001	0.000404	CcSEcCtD
Amisulpride—Dizziness—Carbamazepine—epilepsy syndrome	0.0001	0.000404	CcSEcCtD
Amisulpride—Diarrhoea—Lamotrigine—epilepsy syndrome	0.0001	0.000404	CcSEcCtD
Amisulpride—Headache—Clonazepam—epilepsy syndrome	0.0001	0.000403	CcSEcCtD
Amisulpride—Mental disorder—Topiramate—epilepsy syndrome	0.0001	0.000403	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.98e-05	0.000403	CcSEcCtD
Amisulpride—Constipation—Valproic Acid—epilepsy syndrome	9.94e-05	0.000401	CcSEcCtD
Amisulpride—Headache—Phenytoin—epilepsy syndrome	9.93e-05	0.000401	CcSEcCtD
Amisulpride—Malnutrition—Topiramate—epilepsy syndrome	9.93e-05	0.000401	CcSEcCtD
Amisulpride—Headache—Oxcarbazepine—epilepsy syndrome	9.88e-05	0.000399	CcSEcCtD
Amisulpride—Nausea—Zonisamide—epilepsy syndrome	9.84e-05	0.000397	CcSEcCtD
Amisulpride—Dry mouth—Gabapentin—epilepsy syndrome	9.83e-05	0.000397	CcSEcCtD
Amisulpride—Hypotension—Pregabalin—epilepsy syndrome	9.82e-05	0.000396	CcSEcCtD
Amisulpride—Tension—Topiramate—epilepsy syndrome	9.75e-05	0.000393	CcSEcCtD
Amisulpride—Dizziness—Lamotrigine—epilepsy syndrome	9.67e-05	0.00039	CcSEcCtD
Amisulpride—Nervousness—Topiramate—epilepsy syndrome	9.65e-05	0.000389	CcSEcCtD
Amisulpride—Vomiting—Carbamazepine—epilepsy syndrome	9.62e-05	0.000388	CcSEcCtD
Amisulpride—Muscle spasms—Topiramate—epilepsy syndrome	9.55e-05	0.000385	CcSEcCtD
Amisulpride—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.51e-05	0.000383	CcSEcCtD
Amisulpride—Insomnia—Pregabalin—epilepsy syndrome	9.5e-05	0.000383	CcSEcCtD
Amisulpride—Nausea—Clonazepam—epilepsy syndrome	9.48e-05	0.000383	CcSEcCtD
Amisulpride—Headache—Carbamazepine—epilepsy syndrome	9.48e-05	0.000383	CcSEcCtD
Amisulpride—Nervous system disorder—Gabapentin—epilepsy syndrome	9.45e-05	0.000381	CcSEcCtD
Amisulpride—Nausea—Phenytoin—epilepsy syndrome	9.42e-05	0.00038	CcSEcCtD
Amisulpride—Nausea—Oxcarbazepine—epilepsy syndrome	9.37e-05	0.000378	CcSEcCtD
Amisulpride—Skin disorder—Gabapentin—epilepsy syndrome	9.36e-05	0.000378	CcSEcCtD
Amisulpride—Somnolence—Pregabalin—epilepsy syndrome	9.34e-05	0.000377	CcSEcCtD
Amisulpride—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.32e-05	0.000376	CcSEcCtD
Amisulpride—Tremor—Topiramate—epilepsy syndrome	9.31e-05	0.000375	CcSEcCtD
Amisulpride—Vomiting—Lamotrigine—epilepsy syndrome	9.3e-05	0.000375	CcSEcCtD
Amisulpride—Urticaria—Valproic Acid—epilepsy syndrome	9.23e-05	0.000373	CcSEcCtD
Amisulpride—Abdominal pain—Valproic Acid—epilepsy syndrome	9.19e-05	0.000371	CcSEcCtD
Amisulpride—Headache—Lamotrigine—epilepsy syndrome	9.16e-05	0.00037	CcSEcCtD
Amisulpride—Agitation—Topiramate—epilepsy syndrome	9.13e-05	0.000368	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	9.07e-05	0.000366	CcSEcCtD
Amisulpride—Fatigue—Pregabalin—epilepsy syndrome	9.06e-05	0.000365	CcSEcCtD
Amisulpride—Hypotension—Gabapentin—epilepsy syndrome	9e-05	0.000363	CcSEcCtD
Amisulpride—Nausea—Carbamazepine—epilepsy syndrome	8.99e-05	0.000363	CcSEcCtD
Amisulpride—Constipation—Pregabalin—epilepsy syndrome	8.99e-05	0.000363	CcSEcCtD
Amisulpride—Leukopenia—Topiramate—epilepsy syndrome	8.89e-05	0.000359	CcSEcCtD
Amisulpride—Insomnia—Gabapentin—epilepsy syndrome	8.72e-05	0.000352	CcSEcCtD
Amisulpride—Nausea—Lamotrigine—epilepsy syndrome	8.69e-05	0.000351	CcSEcCtD
Amisulpride—Convulsion—Topiramate—epilepsy syndrome	8.61e-05	0.000347	CcSEcCtD
Amisulpride—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.59e-05	0.000347	CcSEcCtD
Amisulpride—Hypertension—Topiramate—epilepsy syndrome	8.58e-05	0.000346	CcSEcCtD
Amisulpride—Somnolence—Gabapentin—epilepsy syndrome	8.57e-05	0.000346	CcSEcCtD
Amisulpride—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.56e-05	0.000345	CcSEcCtD
Amisulpride—Dyspepsia—Gabapentin—epilepsy syndrome	8.48e-05	0.000342	CcSEcCtD
Amisulpride—Anxiety—Topiramate—epilepsy syndrome	8.43e-05	0.00034	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.4e-05	0.000339	CcSEcCtD
Amisulpride—Urticaria—Pregabalin—epilepsy syndrome	8.35e-05	0.000337	CcSEcCtD
Amisulpride—Asthenia—Valproic Acid—epilepsy syndrome	8.34e-05	0.000336	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.32e-05	0.000336	CcSEcCtD
Amisulpride—Fatigue—Gabapentin—epilepsy syndrome	8.31e-05	0.000335	CcSEcCtD
Amisulpride—Abdominal pain—Pregabalin—epilepsy syndrome	8.31e-05	0.000335	CcSEcCtD
Amisulpride—Dry mouth—Topiramate—epilepsy syndrome	8.27e-05	0.000334	CcSEcCtD
Amisulpride—Constipation—Gabapentin—epilepsy syndrome	8.24e-05	0.000332	CcSEcCtD
Amisulpride—Pruritus—Valproic Acid—epilepsy syndrome	8.22e-05	0.000332	CcSEcCtD
Amisulpride—Diarrhoea—Valproic Acid—epilepsy syndrome	7.95e-05	0.000321	CcSEcCtD
Amisulpride—Nervous system disorder—Topiramate—epilepsy syndrome	7.95e-05	0.000321	CcSEcCtD
Amisulpride—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.88e-05	0.000318	CcSEcCtD
Amisulpride—Skin disorder—Topiramate—epilepsy syndrome	7.87e-05	0.000318	CcSEcCtD
Amisulpride—Hyperhidrosis—Topiramate—epilepsy syndrome	7.84e-05	0.000316	CcSEcCtD
Amisulpride—Hypersensitivity—Pregabalin—epilepsy syndrome	7.74e-05	0.000312	CcSEcCtD
Amisulpride—Dizziness—Valproic Acid—epilepsy syndrome	7.69e-05	0.00031	CcSEcCtD
Amisulpride—Urticaria—Gabapentin—epilepsy syndrome	7.66e-05	0.000309	CcSEcCtD
Amisulpride—Abdominal pain—Gabapentin—epilepsy syndrome	7.62e-05	0.000307	CcSEcCtD
Amisulpride—Hypotension—Topiramate—epilepsy syndrome	7.58e-05	0.000306	CcSEcCtD
Amisulpride—Asthenia—Pregabalin—epilepsy syndrome	7.54e-05	0.000304	CcSEcCtD
Amisulpride—Pruritus—Pregabalin—epilepsy syndrome	7.43e-05	0.0003	CcSEcCtD
Amisulpride—Vomiting—Valproic Acid—epilepsy syndrome	7.39e-05	0.000298	CcSEcCtD
Amisulpride—Insomnia—Topiramate—epilepsy syndrome	7.33e-05	0.000296	CcSEcCtD
Amisulpride—Headache—Valproic Acid—epilepsy syndrome	7.28e-05	0.000294	CcSEcCtD
Amisulpride—Somnolence—Topiramate—epilepsy syndrome	7.21e-05	0.000291	CcSEcCtD
Amisulpride—Diarrhoea—Pregabalin—epilepsy syndrome	7.19e-05	0.00029	CcSEcCtD
Amisulpride—Dyspepsia—Topiramate—epilepsy syndrome	7.14e-05	0.000288	CcSEcCtD
Amisulpride—Hypersensitivity—Gabapentin—epilepsy syndrome	7.1e-05	0.000286	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7e-05	0.000282	CcSEcCtD
Amisulpride—Fatigue—Topiramate—epilepsy syndrome	6.99e-05	0.000282	CcSEcCtD
Amisulpride—Dizziness—Pregabalin—epilepsy syndrome	6.95e-05	0.00028	CcSEcCtD
Amisulpride—Constipation—Topiramate—epilepsy syndrome	6.93e-05	0.00028	CcSEcCtD
Amisulpride—Asthenia—Gabapentin—epilepsy syndrome	6.91e-05	0.000279	CcSEcCtD
Amisulpride—Nausea—Valproic Acid—epilepsy syndrome	6.9e-05	0.000279	CcSEcCtD
Amisulpride—Pruritus—Gabapentin—epilepsy syndrome	6.82e-05	0.000275	CcSEcCtD
Amisulpride—Vomiting—Pregabalin—epilepsy syndrome	6.68e-05	0.00027	CcSEcCtD
Amisulpride—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.63e-05	0.000267	CcSEcCtD
Amisulpride—Diarrhoea—Gabapentin—epilepsy syndrome	6.59e-05	0.000266	CcSEcCtD
Amisulpride—Headache—Pregabalin—epilepsy syndrome	6.58e-05	0.000266	CcSEcCtD
Amisulpride—Urticaria—Topiramate—epilepsy syndrome	6.44e-05	0.00026	CcSEcCtD
Amisulpride—Abdominal pain—Topiramate—epilepsy syndrome	6.41e-05	0.000259	CcSEcCtD
Amisulpride—Dizziness—Gabapentin—epilepsy syndrome	6.37e-05	0.000257	CcSEcCtD
Amisulpride—Nausea—Pregabalin—epilepsy syndrome	6.24e-05	0.000252	CcSEcCtD
Amisulpride—Vomiting—Gabapentin—epilepsy syndrome	6.13e-05	0.000247	CcSEcCtD
Amisulpride—Headache—Gabapentin—epilepsy syndrome	6.04e-05	0.000244	CcSEcCtD
Amisulpride—Hypersensitivity—Topiramate—epilepsy syndrome	5.97e-05	0.000241	CcSEcCtD
Amisulpride—Asthenia—Topiramate—epilepsy syndrome	5.82e-05	0.000235	CcSEcCtD
Amisulpride—Pruritus—Topiramate—epilepsy syndrome	5.74e-05	0.000231	CcSEcCtD
Amisulpride—Nausea—Gabapentin—epilepsy syndrome	5.72e-05	0.000231	CcSEcCtD
Amisulpride—Diarrhoea—Topiramate—epilepsy syndrome	5.55e-05	0.000224	CcSEcCtD
Amisulpride—Dizziness—Topiramate—epilepsy syndrome	5.36e-05	0.000216	CcSEcCtD
Amisulpride—Vomiting—Topiramate—epilepsy syndrome	5.15e-05	0.000208	CcSEcCtD
Amisulpride—Headache—Topiramate—epilepsy syndrome	5.08e-05	0.000205	CcSEcCtD
Amisulpride—Nausea—Topiramate—epilepsy syndrome	4.82e-05	0.000194	CcSEcCtD
Amisulpride—HTR2B—Signaling Pathways—HTR7—epilepsy syndrome	1.26e-05	0.000102	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AVP—epilepsy syndrome	1.25e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	1.24e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRH3—epilepsy syndrome	1.24e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL12—epilepsy syndrome	1.22e-05	9.93e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.22e-05	9.93e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.22e-05	9.93e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—POMC—epilepsy syndrome	1.22e-05	9.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—OPRM1—epilepsy syndrome	1.22e-05	9.91e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.21e-05	9.89e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.21e-05	9.85e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—S100B—epilepsy syndrome	1.21e-05	9.85e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JUNB—epilepsy syndrome	1.2e-05	9.75e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SOCS3—epilepsy syndrome	1.2e-05	9.75e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CNR1—epilepsy syndrome	1.2e-05	9.75e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT3—epilepsy syndrome	1.2e-05	9.74e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDC42—epilepsy syndrome	1.2e-05	9.73e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PLCB1—epilepsy syndrome	1.19e-05	9.72e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.19e-05	9.71e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—POMC—epilepsy syndrome	1.19e-05	9.68e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.17e-05	9.56e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.17e-05	9.52e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR7—epilepsy syndrome	1.17e-05	9.51e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	1.17e-05	9.51e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.17e-05	9.5e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.16e-05	9.47e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AVP—epilepsy syndrome	1.16e-05	9.42e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	1.15e-05	9.36e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NPY—epilepsy syndrome	1.14e-05	9.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.14e-05	9.27e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HBEGF—epilepsy syndrome	1.13e-05	9.24e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	1.12e-05	9.12e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.12e-05	9.12e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT3—epilepsy syndrome	1.11e-05	9.07e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	1.11e-05	9.02e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—POMC—epilepsy syndrome	1.11e-05	9.01e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—S100B—epilepsy syndrome	1.11e-05	9e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—OXT—epilepsy syndrome	1.1e-05	8.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	1.1e-05	8.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CRH—epilepsy syndrome	1.1e-05	8.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	1.1e-05	8.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	1.1e-05	8.94e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SOCS3—epilepsy syndrome	1.09e-05	8.91e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HES1—epilepsy syndrome	1.09e-05	8.91e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDC42—epilepsy syndrome	1.09e-05	8.89e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	1.09e-05	8.87e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADAM10—epilepsy syndrome	1.09e-05	8.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	1.08e-05	8.82e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL2—epilepsy syndrome	1.08e-05	8.81e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.08e-05	8.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	1.08e-05	8.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	1.08e-05	8.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	1.08e-05	8.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.08e-05	8.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.07e-05	8.68e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FYN—epilepsy syndrome	1.06e-05	8.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.06e-05	8.63e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—H2AFX—epilepsy syndrome	1.06e-05	8.63e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MEF2C—epilepsy syndrome	1.06e-05	8.61e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AVP—epilepsy syndrome	1.06e-05	8.61e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—S100B—epilepsy syndrome	1.03e-05	8.37e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.02e-05	8.33e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—YWHAZ—epilepsy syndrome	1.02e-05	8.32e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	1.02e-05	8.31e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	1.02e-05	8.31e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SOCS3—epilepsy syndrome	1.02e-05	8.29e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDC42—epilepsy syndrome	1.02e-05	8.27e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NGF—epilepsy syndrome	1.01e-05	8.23e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.01e-05	8.2e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	1.01e-05	8.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	1e-05	8.18e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	1e-05	8.18e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HES1—epilepsy syndrome	1e-05	8.14e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	9.93e-06	8.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SST—epilepsy syndrome	9.93e-06	8.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	9.93e-06	8.09e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	9.9e-06	8.06e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	9.85e-06	8.01e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AVP—epilepsy syndrome	9.84e-06	8.01e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR5—epilepsy syndrome	9.84e-06	8.01e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	9.77e-06	7.96e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	9.77e-06	7.96e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SST—epilepsy syndrome	9.77e-06	7.96e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	9.72e-06	7.91e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.72e-06	7.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	9.69e-06	7.89e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	9.69e-06	7.89e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	9.68e-06	7.88e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	9.67e-06	7.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HTR2A—epilepsy syndrome	9.63e-06	7.84e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	9.57e-06	7.79e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	9.53e-06	7.75e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	9.35e-06	7.61e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.34e-06	7.6e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	9.34e-06	7.6e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	9.33e-06	7.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HES1—epilepsy syndrome	9.3e-06	7.57e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.3e-06	7.57e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.26e-06	7.54e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	9.24e-06	7.52e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	9.19e-06	7.48e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	9.19e-06	7.48e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	9.18e-06	7.47e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	9.17e-06	7.46e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	9.17e-06	7.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	9.15e-06	7.45e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TSC2—epilepsy syndrome	9.15e-06	7.44e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGT—epilepsy syndrome	9.14e-06	7.44e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	9.13e-06	7.43e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	9.11e-06	7.42e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FYN—epilepsy syndrome	9.05e-06	7.36e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	9.02e-06	7.34e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	9.02e-06	7.34e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—H2AFX—epilepsy syndrome	9.01e-06	7.34e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MEF2C—epilepsy syndrome	9e-06	7.32e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	8.99e-06	7.32e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	8.99e-06	7.32e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOE—epilepsy syndrome	8.95e-06	7.29e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	8.94e-06	7.28e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	8.8e-06	7.16e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	8.8e-06	7.16e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KDR—epilepsy syndrome	8.77e-06	7.14e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—YWHAZ—epilepsy syndrome	8.7e-06	7.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	8.68e-06	7.07e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NGF—epilepsy syndrome	8.6e-06	7e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	8.54e-06	6.95e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	8.52e-06	6.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	8.47e-06	6.89e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PRKCB—epilepsy syndrome	8.44e-06	6.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6ST—epilepsy syndrome	8.41e-06	6.84e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	8.39e-06	6.83e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR5—epilepsy syndrome	8.37e-06	6.81e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	8.36e-06	6.8e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	8.35e-06	6.79e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	8.33e-06	6.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	8.32e-06	6.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	8.29e-06	6.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	8.19e-06	6.67e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR2A—epilepsy syndrome	8.19e-06	6.66e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	8.18e-06	6.66e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	8.15e-06	6.64e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	8.01e-06	6.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—S100B—epilepsy syndrome	7.87e-06	6.41e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	7.8e-06	6.34e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TSC2—epilepsy syndrome	7.78e-06	6.33e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	7.78e-06	6.33e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—epilepsy syndrome	7.77e-06	6.32e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	7.75e-06	6.3e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	7.71e-06	6.28e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—epilepsy syndrome	7.69e-06	6.26e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	7.68e-06	6.25e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	7.67e-06	6.24e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	7.65e-06	6.23e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—epilepsy syndrome	7.61e-06	6.19e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AVP—epilepsy syndrome	7.53e-06	6.13e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—epilepsy syndrome	7.52e-06	6.12e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KDR—epilepsy syndrome	7.46e-06	6.07e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	7.41e-06	6.03e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCB—epilepsy syndrome	7.18e-06	5.84e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6ST—epilepsy syndrome	7.15e-06	5.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HES1—epilepsy syndrome	7.12e-06	5.79e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	7.03e-06	5.72e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	7e-06	5.7e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FYN—epilepsy syndrome	6.92e-06	5.63e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	6.9e-06	5.61e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	6.89e-06	5.6e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	6.88e-06	5.6e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	6.81e-06	5.54e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGF2—epilepsy syndrome	6.8e-06	5.53e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	6.79e-06	5.52e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	6.78e-06	5.51e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.66e-06	5.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NGF—epilepsy syndrome	6.58e-06	5.36e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.55e-06	5.33e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—epilepsy syndrome	6.54e-06	5.32e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	6.47e-06	5.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	6.4e-06	5.21e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	6.4e-06	5.21e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RELA—epilepsy syndrome	6.31e-06	5.14e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	6.3e-06	5.13e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	6.26e-06	5.1e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	6.21e-06	5.06e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	6.19e-06	5.04e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	5.95e-06	4.84e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—epilepsy syndrome	5.94e-06	4.84e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	5.86e-06	4.77e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	5.85e-06	4.76e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—epilepsy syndrome	5.82e-06	4.74e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	5.78e-06	4.71e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	5.77e-06	4.69e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	5.75e-06	4.68e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	5.73e-06	4.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—epilepsy syndrome	5.71e-06	4.64e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	5.69e-06	4.63e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	5.66e-06	4.6e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	5.61e-06	4.57e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JUN—epilepsy syndrome	5.53e-06	4.5e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	5.49e-06	4.47e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	5.47e-06	4.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	5.4e-06	4.4e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	5.38e-06	4.38e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	5.38e-06	4.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RELA—epilepsy syndrome	5.37e-06	4.37e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	5.26e-06	4.28e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.25e-06	4.27e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	5.22e-06	4.25e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	5.2e-06	4.23e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	5.05e-06	4.11e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—epilepsy syndrome	5e-06	4.07e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—epilepsy syndrome	4.96e-06	4.04e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.92e-06	4.01e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.92e-06	4e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.9e-06	3.98e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.89e-06	3.98e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	4.84e-06	3.94e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	4.83e-06	3.93e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	4.82e-06	3.92e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.77e-06	3.88e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JUN—epilepsy syndrome	4.7e-06	3.83e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	4.57e-06	3.72e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	4.53e-06	3.69e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	4.44e-06	3.61e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	4.42e-06	3.6e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.41e-06	3.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	4.35e-06	3.54e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—epilepsy syndrome	4.22e-06	3.43e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	4.11e-06	3.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RELA—epilepsy syndrome	4.11e-06	3.34e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	4.04e-06	3.29e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	4.03e-06	3.28e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.96e-06	3.23e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.74e-06	3.04e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.7e-06	3.01e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.68e-06	2.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3.64e-06	2.97e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JUN—epilepsy syndrome	3.6e-06	2.93e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	3.54e-06	2.88e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	3.5e-06	2.85e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	3.44e-06	2.8e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	3.4e-06	2.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.34e-06	2.72e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—epilepsy syndrome	3.23e-06	2.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	3.18e-06	2.58e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	3.14e-06	2.56e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.09e-06	2.52e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	3.08e-06	2.51e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.82e-06	2.29e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-06	2.13e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.01e-06	1.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.97e-06	1.61e-05	CbGpPWpGaD
